Applications now open!

Pharmacotherapy Level 1 Collaborative


The aim of this collaborative is to support the development of staff quality improvement (QI) skills and improve GP practice processes to support the implementation of Pharmacotherapy Level 1 Services within GP practice teams.


What is Pharmacotherapy Level 1 Services?

The introduction of pharmacotherapy services within GP practices in Scotland is one of the priorities for the transformation of primary care over the next three years. By 2021 pharmacists, pharmacy technicians and assistants will be embedded members of the GP practice teams delivering core and additional elements of the pharmacotherapy service. This is to allow GP's to spend more time with patients and refocus their role on being expert medical generalists as outlined in the 2018 General Medical Services contract in Scotland (GMS 2018).

This collaborative will support the development of practice administrative and pharmacy teams to improve GP practice processes, by adopting and adapting the learning and resources developed in the Practice Administrative Staff Collaborative (PASC) Phase 1.


What are we trying to achieve? 

The focus for implementing Pharmacotherapy Level 1 services will be on performing the selected tasks below:

  • Acute/repeat prescribing
  • Discharge letters
  • Medicines Reconciliation

The aim is to improve the overall outcomes and care experience in primary care for people, families and staff.


Anticipated impact

Following evaluation of PASC Phase 1 it is anticipated that this collaborative will:

  • manage correspondence in a safe and efficient manner
  • reduce the number of documents requiring GP involvement
  • release GP time to focus on their expert medical generalist role
  • ensure processes are in place so medicines related activity can be dealt with by the most appropriate member of the pharmacy team in a timely, safe and efficient way
  • support the development of practice staff roles
  • ensure multidisciplinary practice staff are further supported to develop and extend skills in fields such as QI clinical coding

Further information on the impact can be found in the specification document


Applying and participating 

Pharmacotherapy Level 1 Collaborative is being advertised throughout July and August 2019. Closing date for applications is noon on Friday 23 August 2019. All applications will be assessed by an expert panel comprised of improvement and subject matter experts.

Successful Health and Social Care Partnerships (HSCPs) and GP practices need to be able to clearly demonstrate:

  • why they wish to be involved
  • commitment and support for the project at executive level
  • significant HSCP support
  • support from up to ten GP practice teams to be part of the collaborative and plans for involving patient representatives
  • integration and alignment with other improvement activities within the Primary Care Improvement Portfolio

Successful applicants will be notified week commencing 2 September 2019 and a Memorandum of Understanding will be agreed between Healthcare Improvement Scotland and the HSCP. A copy of the application form can be found here

Please note we are also current recruiting for PASC Phase 2. GP practices should only apply to take part in one of these collaboratives. HSCPs should take a coordinated approach to the recruitment of participating GP practices.

We are also working collaboratively with our Living Well in Communities Portfolio. We will take a coordinated approach to supporting HSCPs and practices who are interested in participating in our Living and Dying Well with Frailty Collaborative. 


Key dates

Collaborative activity Date
Applications open Wednesday 10 July 2019
Closing date for application Friday 23 August 2019
Successful applicants informed w/c 2 September 2019
Inaugural steering group meeting September 2019

National Learning Session 1

Steering group meetings

Data collection

Ongoing testing of resources and learning

November 2019 - February 2020
National Learning Session 2 April 2020
Showcasing Event  September 2020

Any questions?

Please do not hesitate to contact us at